21 C.F.R. Subpart E—Safe Levels for Extralabel Use of Drugs in Animals and Drugs Prohibited From Extralabel Use in Animals
Title 21 - Food and Drugs
(a) In accordance with §530.22, the following safe levels for extralabel use of an approved animal drug or human drug have been established: [Reserved] (b) In accordance with §530.22, the following analytical methods have been accepted by FDA: [Reserved] (a) The following drugs, families of drugs, and substances are prohibited for extralabel animal and human drug uses in food-producing animals. (1) Chloramphenicol; (2) Clenbuterol; (3) Diethylstilbestrol (DES); (4) Dimetridazole; (5) Ipronidazole; (6) Other nitroimidazoles; (7) Furazolidone. (8) Nitrofurazone. (9) Sulfonamide drugs in lactating dairy cattle (except approved use of sulfadimethoxine, sulfabromomethazine, and sulfaethoxypyridazine); (10) Fluoroquinolones; and (11) Glycopeptides. (12) Phenylbutazone in female dairy cattle 20 months of age or older. (b) The following drugs, families of drugs, and substances are prohibited for extralabel animal and human drug uses in nonfood-producing animals: [Reserved] (c) [Reserved] (d) The following drugs, or classes of drugs, that are approved for treating or preventing influenza A, are prohibited from extralabel use in chickens, turkeys, and ducks: (1) Adamantanes. (2) Neuraminidase inhibitors. [62 FR 27947, May 22, 1997, as amended at 67 FR 5471, Feb. 6, 2002; 68 FR 9530, Feb. 28, 2003; 68 FR 14134, Mar. 24, 2003; 71 FR 14377, Mar. 22, 2006]
Title 21: Food and Drugs
PART 530—EXTRALABEL DRUG USE IN ANIMALS
Subpart E—Safe Levels for Extralabel Use of Drugs in Animals and Drugs Prohibited From Extralabel Use in Animals
§ 530.40 Safe levels and availability of analytical methods.
§ 530.41 Drugs prohibited for extralabel use in animals.